<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mishto M</submitter><funding>Cancer Research UK</funding><funding>European Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><pagination>656451</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8082463</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12</volume><pubmed_abstract>Increasing evidence suggests that post-translational peptide splicing can play a role in the immune response under pathological conditions. This seems to be particularly relevant in Type 1 Diabetes (T1D) since post-translationally spliced epitopes derived from T1D-associated antigens have been identified among those peptides bound to Human Leucocyte Antigen (HLA) class I and II complexes. Their immunogenicity has been confirmed through CD4&lt;sup>+&lt;/sup> and CD8&lt;sup>+&lt;/sup> T cell-mediated responses in T1D patients. Spliced peptides theoretically have a large sequence variability. This might increase the frequency of viral-human &lt;i>zwitter&lt;/i> peptides&lt;i>, i.e.&lt;/i> peptides that share a complete sequence homology irrespective of whether they originate from human or viral antigens, thereby imp</pubmed_abstract><journal>Frontiers in immunology</journal><pubmed_title>Potential Mimicry of Viral and Pancreatic β Cell Antigens Through Non-Spliced and &amp;lt;i&amp;gt;cis&amp;lt;/i&amp;gt;-Spliced &amp;lt;i&amp;gt;Zwitter&amp;lt;/i&amp;gt; Epitope Candidates in Type 1 Diabetes.</pubmed_title><pmcid>PMC8082463</pmcid><funding_grant_id>29686</funding_grant_id><funding_grant_id>C67500/A29686</funding_grant_id><pubmed_authors>Mansurkhodzhaev A</pubmed_authors><pubmed_authors>Rodriguez-Calvo T</pubmed_authors><pubmed_authors>Liepe J</pubmed_authors><pubmed_authors>Mishto M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Potential Mimicry of Viral and Pancreatic β Cell Antigens Through Non-Spliced and &amp;lt;i&amp;gt;cis&amp;lt;/i&amp;gt;-Spliced &amp;lt;i&amp;gt;Zwitter&amp;lt;/i&amp;gt; Epitope Candidates in Type 1 Diabetes.</name><description>Increasing evidence suggests that post-translational peptide splicing can play a role in the immune response under pathological conditions. This seems to be particularly relevant in Type 1 Diabetes (T1D) since post-translationally spliced epitopes derived from T1D-associated antigens have been identified among those peptides bound to Human Leucocyte Antigen (HLA) class I and II complexes. Their immunogenicity has been confirmed through CD4&lt;sup>+&lt;/sup> and CD8&lt;sup>+&lt;/sup> T cell-mediated responses in T1D patients. Spliced peptides theoretically have a large sequence variability. This might increase the frequency of viral-human &lt;i>zwitter&lt;/i> peptides&lt;i>, i.e.&lt;/i> peptides that share a complete sequence homology irrespective of whether they originate from human or viral antigens, thereby imp</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-05-08T06:04:40.368Z</modification><creation>2022-02-10T08:55:03.863Z</creation></dates><accession>S-EPMC8082463</accession><cross_references><pubmed>33936085</pubmed><doi>10.3389/fimmu.2021.656451</doi></cross_references></HashMap>